David C. Booth, MD

Original Contribution

Impact of Drug-Eluting Stents on Outcomes of Patients with
End-Stage Renal Disease Undergoing Percutaneous Coronary Revasculari

08/01/2008

Khaled M. Ziada , MD;

David J. Moliterno , MD;

Richard Charnigo , MD;

J. Darrell Sneed , MD;

David C. Booth , MD;

Debabrata Mukherjee , MD, MS;

Pranab Das , MD;

Steven R. Steinhubl , MD;

Several randomized trials have demonstrated the efficacy of drug-eluting stents (DES) in reducing restenosis and the need for target vessel revascularization (TVR) in comparison to bare metal stents (BMS).1-3 Patient and lesion subsets...

Several randomized trials have...

08/01/2008

Journal of Invasive Cardiology

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

December 12 ⁠–⁠ December 13

December 14 ⁠–⁠ December 15

February 2 ⁠–⁠ February 5

February 27 ⁠–⁠ March 1

March 17 ⁠–⁠ March 19

See Full Calendar

David C. Booth, MD

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products